Last reviewed · How we verify
NCT07101263
Whey Protein Comparisons for Blood Lipid Effects
NA trial testing Standard whey in Cholesterol in 72 participants. Currently enrolling.
23 December 2025
Quick facts
| Lead sponsor | Medinutra LLC |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 72 |
| Start date | 5 August 2025 |
| Primary completion | 23 December 2025 |
| Estimated completion | 15 January 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Standard whey
- Hydrolyzed whey
Conditions studied
- Cholesterol — all drugs for Cholesterol →
Sponsor
Medinutra LLC
Who can join
Adults 21 to 59, any sex, with Cholesterol. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn if hydrolyzed whey protein can help serum cholesterol stay in normal range in adults. As a side inquiry, a few blood measures will be taken that are relevant to low level inflammation. The main questions the study aims to answer are: * Will hydrolyzed whey lower serum cholesterol readings in adults with starting values in the upper end of normal to the lower end of elevated? * Will the hydrolyzed whey affect a general measure of inflammation and two measures of indirect relevance to inflammation? Researchers will compare hydrolyzed whey to a conventional whey (a control protein not expected to affect serum cholesterol readings) to see if the hydrolyzed whey lowers serum cholesterol. Participants will: * Drink one protein beverage every day for 6 weeks; * Go to a LabCorp facility for a blood draw before and after the 6 weeks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07101263
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cholesterol
Currently open trials in the same condition.
- NCT06919302 — The Effect of a Digital Heart Health App and Lifestyle Intervention for Heart Disease in Primary Care. · NA · recruiting
- NCT05050266 — Enhancing Mental and Physical Health of Women Veterans · NA · active not recruiting
- NCT07252830 — Identification of Asymptomatic Patients at Very High Cardiovascular Risk: Contribution of a Strategy Based on Carotid an · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07101263 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medinutra LLC
- Last refreshed: 8 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07101263.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing